Bio-Rad Laboratories Inc (NYSE:BIO)
$ 286.86 4.85 (1.72%) Market Cap: 8.15 Bil Enterprise Value: 7.90 Bil PE Ratio: 0 PB Ratio: 0.90 GF Score: 73/100

Q2 2019 Bio Rad Laboratories Inc Earnings Call Transcript

Aug 01, 2019 / 09:00PM GMT
Release Date Price: $310.37 (-1.44%)
Operator

Good day, ladies and gentlemen, and welcome to Bio-Rad Laboratories' Second Quarter 2019 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to Ron Hutton, Treasurer and Vice President. You may begin.

Ronald W. Hutton
Bio-Rad Laboratories, Inc. - VP & Treasurer

Thank you, Tiphanie. Good afternoon, and thank you all for joining us today. Today, we will review the second quarter financial results for 2019. With me today are Norman Schwartz, our CEO; Ilan Daskal, Executive Vice President and Chief Financial Officer; Andy Last, Executive Vice President and Chief Operating Officer; Annette Tumolo, President of the Life Science Group; and John Hertia, President of the Clinical Diagnostics Group.

Before we begin our review, I would like to caution everyone that we will be making forward-looking statements about management's goals, plans and expectations, our future financial performance and other matters. Because our actual results may differ materially from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot